Speaker Profile
M.D., PHARMD, MSHS, President, Grail Bio
Biography
Joshua J. Ofman- Prior to joining GRAIL in 2019, Josh spent 16 years at Amgen, where he held various roles, most recently Senior Vice President, Global Value, Access and Policy. Prior to that, Josh was a faculty member in the Department of Medicine and Health Services Research at the University of California, Los Angeles (UCLA) School of Medicine, Cedars-Sinai Medical Center, as well as Senior Vice President of Zynx Health Inc., a subsidiary of Cerner Corp. Josh currently serves on the Board of Directors of the Precision Medicine Coalition and has previously served on the Board of Directors of Cell BT Inc, a biotechnology company developing CAR-T cell therapeutics. Josh holds a BA in history and philosophy of science from the University of California, Berkeley, and an MD from the University of California, Irvine, School of Medicine. Josh also has an MSHS from the UCLA School of Public Health.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Adrian Lee, UPMC
- PMWC Award Ceremony
Pioneer Honoree: Victor Velculescu, Johns Hopkins
Luminary Honoree: Nicola Aceto, ETH Zurich
- Keynote: Early Detection of Cancer using Cell-free DNA Fragmentomes
- Victor Velculescu, Johns Hopkins - Keynote: Circulating Tumor Cells
- Nicola Aceto, ETH Zurich - Innovative Approaches in Liquid Biopsy (PANEL)
Chair: Victor Velculescu, Johns Hopkins
- Adam Widman, MSKCC
- Improving Sensitivity of MRD and MCED - Tumor-agnostic vs. Tumor-informed ctDNA Approaches
Chair: Adrian Lee, University of Pittsburgh
- Marija Balic, UPMC
- Ola Carl Landgren, University of Miami - Sequencing Accuracy in Early Detection and MRD (PANEL)
Chair: Alex Sockell, PacBio
- James Hadfield, AstraZeneca
- Cristian Tomasetti, City of Hope
- Circulating Tumor Cells: The New Frontier (PANEL)
Chair: Nicola Aceto, ETH Zurich
- Min Yu, University of Maryland School of Medicine
- Matteo Ligorio, UTSW - Addressing Key Challenges and Questions in MCED Testing: Clinical Validation, Overdiagnosis, and Diagnostic Pathways
Chair: Tom Beer, Exact Sciences
- PMWC Showcase
- Wendy Winckler, Droplet Biosciences - Multi-Cancer Early Detection: Innovations and Real-World Evidence (PANEL)
Chair: Peter Bach, Delphi Dx
- Joshua Cohen, Haystack
- Lauren Leiman, BLOODPAC
- Josh Ofman, Grail Bio
- Tom Beer, Exact Sciences - PMWC Showcase
- Varsha Rao, Claret Bio
